DESIGNING OF A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLEBLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN INHIBITOR, IN ADULTS WITH PRIMARY SJOGREN'S SYNDROME-MedSci.cn

DESIGNING OF A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLEBLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN INHIBITOR, IN ADULTS WITH PRIMARY SJOGREN'S SYNDROME

Hubbard, J; Campbell, K; Sivils, K; Hoffman, R; Lo, KH; Leu, JH; Bowman, S; Liva, S; Zuraw, Q; Stevens, AM; Ling, L; Karcher, K; Ramchandren, S; Sun, H; Scofield, RH; Seror, R; Wallace, DJ

ANNALS OF THE RHEUMATIC DISEASES, 2023; 82 (): 892

科室
- - 订阅+
  - 更多科室
工具
服务